Katy Beckermann, Medical Director of GU Clinical Research at Tennessee Oncology, shared on X:
“Day 1 of KCRS26 starts today in Boston.
Before the sessions kick off, the science is available to all:
Excited to dig into the details today.”
You can also read ‘PSMA PET/CT Guidance Linked to Longer Biochemical Control in Oligometastatic Castration-Resistant Prostate Cancer‘
